Related references
Note: Only part of the references are listed.Emerging Insights into the Ependymoma Epigenome
Stephen C. Mack et al.
BRAIN PATHOLOGY (2013)
The efficacy of temozolomide for recurrent glioblastoma multiforme
Chao Chen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53null Cell Lines
Elisabeth Silden et al.
PLOS ONE (2013)
Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death
Hazel A. Rogers et al.
ACTA NEUROPATHOLOGICA (2012)
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Jeffrey A. Magee et al.
CANCER CELL (2012)
Temozolomide in relapsed pediatric brain tumors: 14 cases from a single center
Canan Akyuz et al.
CHILDS NERVOUS SYSTEM (2012)
Molecular approaches to ependymoma: the next step(s)
Hendrik Witt et al.
CURRENT OPINION IN NEUROLOGY (2012)
Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models
Tiziana Servidei et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Epigenetic alterations involved in cancer stem cell reprogramming
Purificacion Munoz et al.
MOLECULAR ONCOLOGY (2012)
BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression
L. Persano et al.
CELL DEATH & DISEASE (2012)
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat
Till Milde et al.
ACTA NEUROPATHOLOGICA (2011)
An Integrated In Vitro and In Vivo High-Throughput Screen Identifies Treatment Leads for Ependymoma
Jennifer M. Atkinson et al.
CANCER CELL (2011)
Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma
Hendrik Witt et al.
CANCER CELL (2011)
Extent and Patterns of MGMT Promoter Methylation in Glioblastoma- and Respective Glioblastoma-Derived Spheres
Davide Sciuscio et al.
CLINICAL CANCER RESEARCH (2011)
The Transcription Factor Evi-1 Is Overexpressed, Promotes Proliferation, and Is Prognostically Unfavorable in Infratentorial Ependymomas
Bjoern Koos et al.
CLINICAL CANCER RESEARCH (2011)
INFANT EPENDYMOMA IN A 10-YEAR AIEOP (ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA) EXPERIENCE WITH OMITTED OR DEFERRED RADIOTHERAPY
Maura Massimino et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion
Deema Hussein et al.
NEURO-ONCOLOGY (2011)
Establishment and characterization of clinically relevant models of ependymoma: a true challenge for targeted therapy
Su Guan et al.
NEURO-ONCOLOGY (2011)
MEK-ERK Signaling Dictates DNA-Repair Gene MGMT Expression and Temozolomide Resistance of Stem-Like Glioblastoma Cells via the MDM2-p53 Axis
Atsushi Sato et al.
STEM CELLS (2011)
MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase-Mediated HOX/Stem Cell Gene Signature
Nathalie Gaspar et al.
CANCER RESEARCH (2010)
Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysis
Stergios Zacharoulis et al.
CHILDS NERVOUS SYSTEM (2010)
Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells
Benito Campos et al.
CLINICAL CANCER RESEARCH (2010)
Rapid and Robust Transgenic High-Grade Glioma Mouse Models for Therapy Intervention Studies
Nienke A. de Vries et al.
CLINICAL CANCER RESEARCH (2010)
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Michael Weller et al.
NATURE REVIEWS NEUROLOGY (2010)
Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma
Doo-Sik Kong et al.
NEURO-ONCOLOGY (2010)
Sensitivity to temozolomide in brain tumor initiating cells
Michael D. Blough et al.
NEURO-ONCOLOGY (2010)
The DNA methylome of glioblastoma multiforme
Ramon Martinez et al.
NEUROBIOLOGY OF DISEASE (2010)
O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation is significantly less frequent in ependymal tumours as compared to malignant astrocytic gliomas
B. Koos et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2010)
The Isoforms of the p53 Protein
Marie P. Khoury et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment with etoposide and temozolomide
Yuichi Sato et al.
CANCER BIOLOGY & THERAPY (2009)
Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
Claire Banissi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Quantitative Assessment of the Complex Dynamics of G1, S, and G2-M Checkpoint Activities
Paolo Ubezio et al.
CANCER RESEARCH (2009)
PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
Anne-Marie Bleau et al.
CELL STEM CELL (2009)
Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma
Jennifer L. Clarke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Pediatric Ependymoma: Biological Perspectives
John-Paul Kilday et al.
MOLECULAR CANCER RESEARCH (2009)
Cell cycle kinases as therapeutic targets for cancer
Silvia Lapenna et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Brain cancer propagating cells: biology, genetics and targeted therapies
Costas G. Hadjipanayis et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective
Judith M. de Bont et al.
NEURO-ONCOLOGY (2008)
Temozolomide induces senescence but not apoptosis in human melanoma cells
N. M. Mhaidat et al.
BRITISH JOURNAL OF CANCER (2007)
Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study
Richard G. Grundy et al.
LANCET ONCOLOGY (2007)
Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O-6-methylguanine
W. P. Roos et al.
ONCOGENE (2007)
Radial glia cells are candidate stem cells of ependymoma
MD Taylor et al.
CANCER CELL (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules
AW Tolcher et al.
BRITISH JOURNAL OF CANCER (2003)
New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?
O Coqueret
TRENDS IN CELL BIOLOGY (2003)
Metronomic scheduling: the future of chemotherapy?
G Gasparini
LANCET ONCOLOGY (2001)
Share Paper
